PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
PetVivo's revenue for the twelve months ending Jun 30, 2026 was $1.18M, down 9.5% year over year. For fiscal 2026 it was $1.14M, up 0.8% from the year before. The highest annual figure on record is $1.14M in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.14M | +0.8% |
| FY2025 | Mar 31, 2025 | $1.13M | +16.9% |
| FY2024 | Mar 31, 2024 | $968.71K | +5.6% |
| FY2023 | Mar 31, 2023 | $917.16K | +693.5% |
| FY2022 | Mar 31, 2022 | $115.59K | +819.0% |
| FY2021 | Mar 31, 2021 | $12.58K | +250.6% |
| FY2020 | Mar 31, 2020 | $3.59K | +137.6% |
| FY2018 | Mar 31, 2018 | $1.51K | -78.8% |
| FY2017 | Mar 31, 2017 | $7.12K | -90.5% |
| FY2016 | Mar 31, 2016 | $75.00K | – |
| FY2012 | Mar 31, 2012 | $0 | – |
| FY2011 | Mar 31, 2011 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $337.57K | +13.5% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $254.72K | +13.3% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $286.11K | -51.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $303.28K | +51.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $297.50K | +140.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $224.75K | +365.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $583.31K | -2.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $200.72K | -3.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $123.75K | +5.6% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $48.27K | -61.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $595.89K | +16.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $207.37K | -7.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $117.18K | +101.4% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $125.60K | +126.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $510.11K | +900.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $223.28K | +4386.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $58.17K | +1303.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $55.46K | +951.4% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $51.00K | +9960.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $4.98K | +3.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $4.15K | +106.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $5.28K | +70.8% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $507 | +1.4% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $4.79K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $2.01K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $3.09K | +844.3% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $500 | -57.7% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $0 | -100.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $0 | -100.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $327 | -88.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.18K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $45 | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $2.16K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.91K | – |
See a number that looks wrong?